GlassScriptPhysician profile
Corey J Wolff
NPI 1275628752
$2,467.79
in general payments reported to CMS, 2019-2025
16 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $622 · 2020: $494 · 2021: $304 · 2022: $216 · 2023: $377 · 2024: $287 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.67 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $566.53 | 2019-2024 | Jornay Pm |
| Tris Pharma INC | $479.71 | 2019-2024 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $308.27 | 2021-2025 | Qelbree, Qelbree |
| Neos Therapeutics, LP | $294.29 | 2019-2025 | Cotempla Xr-Odt |
| Corium, LLC | $243.50 | 2021-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $160.74 | 2020-2021 | |
| Pfizer INC. | $75.96 | 2021-2023 | |
| Adlon Therapeutics L.P. | $65.31 | 2020-2021 | |
| Sanofi Pasteur INC. | $58.57 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $56.31 | 2019-2024 | Gardasil 9, Gardasil, Vaxneuvance |
| Shire North American Group INC | $37.68 | 2019 | |
| Glaxosmithkline, LLC. | $35.87 | 2024-2025 | Bexsero |
| Collegium Pharmaceutical, INC. | $33.69 | 2025 | Jornay Pm |
| Cranial Technologies, INC | $19.99 | 2025 | Doc Band |
| Abbvie INC. | $18.52 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Wolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.